FinancialVu

Market News and Views

You are here: Home / Top Stories / : After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology

: After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology

by

Roivant shares gain more than 10% after narrower-than-expected quarterly loss.